Amyloidosis trials in Sweden

5 of 15 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting

  Where

  Multiple Locations

  Age

  18 years and over

  People

  2,000 worldwide

  Run by

  Bayer

  See details and how to joinNCT07235462
• No phaseTaking people
  OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis

  Where

  Södertälje, Umeå

  People

  52,121 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06355934
• No phaseTaking people
  Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM

  Where

  Gothenburg, Solna, Vasterbottens Lan

  Age

  18 years and over

  People

  500 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07690436
• Phase 2/3Enrolling by invitation
  Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001

  Where

  Umea

  Age

  18 years and over

  People

  72 worldwide

  Run by

  Intellia Therapeutics

  See details and how to joinNCT05697861 · EU 2023-507385-11-00
• No phaseEnrolling by invitation
  Sahlgrenska Cardiomyopathy Project

  Where

  Gothenburg

  Age

  18 years to 99 years

  People

  3,000

  Run by

  Göteborg University

  See details and how to joinNCT03527342